Phase 2 Study of a Chikungunya Vaccine in Previously Exposed Adults

Condition:   Chikungunya Virus Infection Interventions:   Biological: MV-CHIK;   Other: Placebo Sponsors:   Themis Bioscience GmbH;   Walter Reed Army Institute of Research (WRAIR) Not yet recruiting

Source: ClinicalTrials.gov - January 17, 2019 Category: Research Source Type: clinical trials